SM
CLVS

Sabby Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Sabby Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-7,065
Closed -$560K – 224
2017
Q2 		$661K Buy
+7,065
New +$432K 0.04% 122
2016
Q3 		– Sell
-59,836
Closed -$1.28M – 348
2016
Q2 		$821K Buy
59,836
+46,510
+349% +$680K 0.04% 174
2016
Q1 		$256K Sell
13,326
-7,597
-36% -$161K 0.01% 250
2015
Q4 		$732K Buy
+20,923
New +$1.35M 0.04% 210
2014
Q3 		– Sell
-20,000
Closed -$828K – 308
2014
Q2 		$828K Buy
+20,000
New +$1.03M 0.04% 164

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return